Insulin prices have skyrocketed, putting drug makers on the defensive Posted on April 9, 2016 by henrykotula • Posted in Uncategorized • Tagged AMA, CDC, Diabetes Care Management, Health Policy, Insulin, Medicare Part D, Pharmaceutical Industry, Prescription Drug Costs, Public Health • Leave a comment Insulin prices have skyrocketed, putting drug makers on the defensive Share this: Share on X (Opens in new window) X Share on Facebook (Opens in new window) Facebook Share on LinkedIn (Opens in new window) LinkedIn Like Loading... Related
